These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2764538)

  • 1. Single-dose enoxacin compared with 3-day treatment for urinary tract infection.
    Backhouse CI; Matthews JA
    Antimicrob Agents Chemother; 1989 Jun; 33(6):877-80. PubMed ID: 2764538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.
    Patel SS; Spencer CM
    Drugs; 1996 Jan; 51(1):137-60. PubMed ID: 8741236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
    Gottlieb PL
    Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.
    Talbot GH; Cassileth PA; Paradiso L; Correa-Coronas R; Bond L
    Antimicrob Agents Chemother; 1993 Mar; 37(3):474-82. PubMed ID: 8460916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
    Germinario C; Quarto M; Viggiani N; Schena FP
    Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of enoxacin].
    Zhang YY; Zhun BY; Jiang SC
    Zhonghua Nei Ke Za Zhi; 1991 Aug; 30(8):480-3, 521. PubMed ID: 1794242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Henwood JM; Monk JP
    Drugs; 1988 Jul; 36(1):32-66. PubMed ID: 3063494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxacin in urinary tract infections associated with gynecological diseases.
    De Cecco L; Leone M
    J Chemother; 1989 Jul; 1(4 Suppl):886-7. PubMed ID: 16312687
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
    Tizzani A; Casetta G; Cavallini A; Piana P
    Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
    Childs SJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections.
    Cox CE; Drylie DM; Klimberg I; Childs SJ; Wegenke JD; Malek GH; Harrison LH; McCullough DL; Finegold SM; George WL
    J Urol; 1989 Mar; 141(3):575-8. PubMed ID: 2645421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea.
    Albrecht LM; Rybak MJ; Schubiner HH; Weiner LM
    Sex Transm Dis; 1989; 16(2):114-7. PubMed ID: 2500718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxacin relieves symptoms of recurrent urinary infections more rapidly than cefuroxime axetil.
    Brumfitt W; Hamilton-Miller JM; Walker S
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1558-9. PubMed ID: 8363392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.